State of Industry 4.0 in Life Sciences

This IDC Perspective examines the ongoing evolution of Industry 4.0 in life sciences, providing insights into technology adoption trends, investment priorities, and the improvements to manufacturing and supply chain processes enabled by new and emerging technologies such as IoT, AI and GenAI, and digital twins. The document highlights how these technologies create new opportunities for process optimization and cost efficiency, offering actionable guidance to help life sciences organizations build a more agile, resilient, and intelligent manufacturing and supply chain ecosystem through Industry 4.0 initiatives. "In today's life sciences landscape, organizations that embrace Industry 4.0 best practices and master AI-driven tools for decision intelligence are best positioned to lead with efficiency, agility, and resilience," says Nino Giguashvili, research manager, IDC Health Insights Life Sciences Commercial Strategies.